PubRank

Daniel Hayoz

Author PubWeight™ 78.95‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006 17.53
2 The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 2008 5.33
3 Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: a monitoring test of endothelial dysfunction for clinical practice? J Am Coll Cardiol 2003 2.59
4 Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. Am J Med 2004 2.22
5 Are circulating endothelial-derived and platelet-derived microparticles a pathogenic factor in the cisplatin-induced stroke? Stroke 2007 2.17
6 Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors. Circulation 2002 1.94
7 Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction. Circulation 2004 1.90
8 Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice. Hypertension 2004 1.89
9 Postischemic forearm skin reactive hyperemia is related to cardovascular risk factors in a healthy female population. J Hypertens 2002 1.64
10 Confounding effects of heart rate on pulse wave velocity in paced patients with a low degree of atherosclerosis. J Hypertens 2004 1.47
11 Single-blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins. Dermatol Surg 2004 1.45
12 High prevalence of peripheral arterial disease in HIV-infected persons. Clin Infect Dis 2008 1.34
13 Low-pressure environment and remodelling of the forearm vein in Brescia-Cimino haemodialysis access. Nephrol Dial Transplant 2002 1.29
14 Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study. Eur J Cardiovasc Prev Rehabil 2009 1.22
15 Alcohol drinking and cardiovascular risk in a population with high mean alcohol consumption. Am J Cardiol 2008 1.12
16 Intravenous fish oil blunts the physiological response to endotoxin in healthy subjects. Intensive Care Med 2007 1.10
17 Increased carotid intima-media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease. Acta Paediatr Suppl 2006 1.04
18 Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine. Hypertension 2008 1.02
19 Diabetic neuropathy is a more important determinant of baroreflex sensitivity than carotid elasticity in type 2 diabetes. Hypertension 2005 1.01
20 Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition. Arterioscler Thromb Vasc Biol 2006 1.00
21 Vascular risk factors in the Swiss population. J Neurol 2005 0.95
22 Cap G, a gelsolin family protein modulating protective effects of unidirectional shear stress. J Biol Chem 2003 0.94
23 Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland. Eur J Cardiovasc Prev Rehabil 2008 0.91
24 Characterization of human late outgrowth endothelial progenitor-derived cells under various flow conditions. J Vasc Res 2011 0.90
25 Shear stress and cyclic circumferential stretch, but not pressure, alter connexin43 expression in endothelial cells. Cell Commun Adhes 2006 0.89
26 Increased connexin43 expression in human saphenous veins in culture is associated with intimal hyperplasia. J Vasc Surg 2005 0.88
27 Predictive accuracy of original and recalibrated Framingham risk score in the Swiss population. Int J Cardiol 2008 0.88
28 Tissue factor activity is upregulated in human endothelial cells exposed to oscillatory shear stress. Thromb Haemost 2002 0.88
29 Ambulatory blood pressure monitoring: a mean to stratify cardiovascular risk. Blood Press Monit 2007 0.88
30 Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy. Blood 2006 0.87
31 The impact of carotid plaque screening on motivation for smoking cessation. Nicotine Tob Res 2008 0.86
32 Clinical prediction of deep venous thrombosis using two risk assessment methods in combination with rapid quantitative D-dimer testing. Am J Med 2002 0.86
33 Prevalence of normal weight obesity in Switzerland: effect of various definitions. Eur J Nutr 2008 0.85
34 Swimming prevents vulnerable atherosclerotic plaque development in hypertensive 2-kidney, 1-clip mice by modulating angiotensin II type 1 receptor expression independently from hemodynamic changes. Hypertension 2009 0.85
35 Severe hyperlipidemia causes impaired renin-angiotensin system function in apolipoprotein E deficient mice. Atherosclerosis 2005 0.84
36 Acute endotoxemia inhibits microvascular nitric oxide-dependent vasodilation in humans. Shock 2011 0.82
37 [The culture of "useful error" in health care establishments: impact of morbidity and mortality conferences (MMCs)]. Rev Med Suisse 2010 0.82
38 Surrogate markers for atherosclerosis in overweight subjects with atherogenic dyslipidemia: the GEMS project. Angiology 2008 0.82
39 Intravital microscopy reveals endothelial dysfunction in resistance arterioles in Angiotensin II-induced hypertension. Hypertens Res 2012 0.82
40 Aspirin use for the primary prevention of coronary heart disease: a population-based study in Switzerland. Prev Med 2007 0.81
41 High prevalence of unsuspected abdominal aortic aneurysms in patients hospitalised for surgical coronary revascularisation. Eur J Cardiothorac Surg 2004 0.80
42 Predictors of in-hospital mortality in elderly patients with acute venous thrombo-embolism: the SWIss Venous ThromboEmbolism Registry (SWIVTER). Eur Heart J 2011 0.80
43 ET-1 and NOS III gene expression regulation by plaque-free and plaque-prone hemodynamic conditions. Biorheology 2003 0.79
44 Sealing pseudo-aneurysms of the femoral artery with saline injection: a new technique. EuroIntervention 2012 0.79
45 D-dimers testing is not recommended for the exclusion of deep vein thrombosis in outpatients with lower limb erysipelas. Thromb Haemost 2002 0.78
46 Endogenous estrogens increase postischemic hyperemia in the skin microcirculation. J Cardiovasc Pharmacol 2005 0.78
47 The renin-angiotensin system and atherosclerosis. Curr Hypertens Rep 2006 0.78
48 Transcriptional and post-transcriptional regulation of preproendothelin-1 by plaque-prone hemodynamics. Atherosclerosis 2007 0.77
49 Rivaroxaban for the treatment of venous thromboembolism. The SWIss Venous ThromboEmbolism Registry (SWIVTER). Thromb Haemost 2016 0.77
50 Success of thrombolysis as a predictor of outcome in acute thrombosis of popliteal aneurysms. J Vasc Surg 2002 0.77
51 The Impact of CAROtid plaque Screening on Smoking (CAROSS) cessation and control of other cardiovascular risk factors: Rationale and design of a randomized controlled trial. Contemp Clin Trials 2008 0.76
52 Reduction of small infrarenal abdominal aortic aneurysm expansion rate by statins. Vasa 2012 0.76
53 Management and prognosis of status epilepticus according to hospital setting: a prospective study. Swiss Med Wkly 2009 0.76
54 Magnesium supplementation and deoxycorticosterone acetate--salt hypertension: effect on arterial mechanical properties and on activity of endothelin-1. Can J Physiol Pharmacol 2002 0.76
55 Compression after sclerotherapy for telangiectasias and reticular leg veins: a randomized controlled study. J Vasc Surg 2007 0.76
56 Time course of the inflammatory response after endovascular repair of aortic aneurysms. Eur J Cardiothorac Surg 2007 0.75
57 AT1 receptor antagonists: vascular protection beyond blood pressure reduction? J Hypertens 2002 0.75
58 Artificial muscle for end-stage heart failure. ASAIO J 2012 0.75
59 Left ventricular hypertrophy and remodelling of resistance arteries: the role of activation of the renin-angiotensin-aldosterone system in hypertension. J Hypertens 2002 0.75
60 [Antibiotic induced hepatotoxicity]. Rev Med Suisse 2010 0.75
61 [Acute myocardial infarction: importance of the networking in the initial management]. Rev Med Suisse 2010 0.75
62 [The "orphans" of the vascular system]. Rev Med Suisse 2006 0.75
63 Prevalence and characteristics of homeopathy users in a representative sample of the Lausanne population: CoLaus study. Pharmacoepidemiol Drug Saf 2008 0.75
64 The effect of valsartan versus non-RAAS treatment on autoregulation of cerebral blood flow. Cerebrovasc Dis 2012 0.75
65 [Aortic calcification and the risk of osteoporotic fractures]. Rev Med Suisse 2010 0.75
66 Lower limb high arterial flow induced by tenofovir and emtricitabine treatment. Antivir Ther 2009 0.75
67 Totally implantable robot to treat chronic atrial fibrillation. Bioinspir Biomim 2008 0.75
68 Incidence of gestational diabetes and birth complications in Switzerland: screening in 1042 pregnancies. Gynecol Endocrinol 2014 0.75
69 Active mitral ring for post-surgical remote correction of residual mitral regurgitation on the beating heart. Eur J Cardiothorac Surg 2013 0.75
70 [Angiography: need for a multidisciplinary approach]. Rev Med Suisse 2009 0.75
71 Artificial muscles to restore transport function of diseased atria. ASAIO J 2008 0.75
72 Exclusion of pulmonary embolism using C-reactive protein and D-dimer. A prospective comparison. Thromb Haemost 2003 0.75
73 Progress in cardiovascular anastomoses: will the vascular join replace Carrel's technique? Eur J Cardiothorac Surg 2006 0.75
74 Artificial muscle to wash blood out of fibrillating atrium: an alternative to lifelong anticoagulation. ASAIO J 2009 0.75
75 Atria assist device to restore transport function of fibrillating atrium. Eur J Cardiothorac Surg 2007 0.75
76 [Preoperative assessment of peripheral arteriopathy]. Rev Med Suisse Romande 2004 0.75
77 [Peripheric arteriopathy: focus in 2007]. Rev Med Suisse 2007 0.75
78 Endovascular surgery for failed open aortic aneurysm repair. Eur J Cardiothorac Surg 2004 0.75
79 Effect of an intravenous bolus of phenylephrine or ephedrine on skin blood flow during spinal anaesthesia: a randomised, double-blind, controlled study. Eur J Anaesthesiol 2011 0.75
80 [Cardiovascular markers]. Rev Med Suisse 2009 0.75
81 [Medical therapy in peripheral arterial occlusive disease]. Rev Med Suisse 2009 0.75
82 Mastering Mitral Leaflets Coaptation after Valve Repair with Adjustable Mitral Annuloplasty Ring: prove of concept in mock loop study. ASAIO J 2016 0.75
83 [Hematuria: which algorithm for an effective diagnostic strategy?]. Rev Med Suisse 2010 0.75
84 Peripheral oedema and high arterial blood flow as a complication of antiretroviral therapy. AIDS 2004 0.75
85 [Fribourg to zenith?]. Rev Med Suisse 2010 0.75
86 Predictors of thromboprophylaxis in hospitalised medical patients. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE). Thromb Haemost 2015 0.75
87 Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) and contrast-induced acute kidney injury after coronary angiogram. Swiss Med Wkly 2013 0.75
88 Myelofibrosis and spinal cord ischaemia. Thromb Haemost 2009 0.75
89 Biometal muscle to restore atrial transport function in a permanent atrial fibrillation animal model: a potential tool in the treatment of end-stage heart failure. Eur J Cardiothorac Surg 2009 0.75